Edesa Biotech (EDSA) Announces 1:7 Reverse Share Split

Edesa Biotech, Inc. (NASDAQ: EDSA) today is announcing that it intends to effect a one-for-seven reverse share split of its common shares. The Company's common shares will continue to be traded on The Nasdaq Capital Market under the symbol "EDSA" and will begin trading on a post-reverse split basis when the market opens on Wednesday, October 11, 2023, under a new CUSIP number, 27966L306.

As a result of the reverse share split, every seven shares of Edesa common shares will be combined into one common share. The reverse share split, known as a share consolidation under applicable British Columbia law, does not affect any shareholder's ownership percentage of the Company's common shares or proportional voting power, except to the extent that the share consolidation would result in any fractional shares. No fractional shares will be issued, and any fraction will be rounded to the nearest whole share in accordance with the Business Corporations Act (British Columbia).

You May Also Be Interested In

• Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
• VICI Properties closes $1.75B senior unsecured notes offering
• Optimum Communications gets NYSE non-compliance notice over stock price